AAAAAA

   
Results: 1-9 |
Results: 9
Managing the highly sensitized transplant recipient and B cell tolerance
Authors: Baid, S Saidman, SL Tolkoff-Rubin, N Williams, WW Delmonico, FL Cosimi, AB Pascual, M
Citation: S. Baid et al., Managing the highly sensitized transplant recipient and B cell tolerance, CURR OP IM, 13(5), 2001, pp. 577-581
Control of antidonor antibody production with tacrolimus and mycophenolatemofetil in renal allograft recipients with chronic rejection
Authors: Theruvath, TP Saidman, SL Mauiyyedi, S Delmonico, FL Williams, WW Tolkoff-Rubin, N Collins, AB Colvin, RB Cosimi, AB Pascual, M
Citation: Tp. Theruvath et al., Control of antidonor antibody production with tacrolimus and mycophenolatemofetil in renal allograft recipients with chronic rejection, TRANSPLANT, 72(1), 2001, pp. 77-83
Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics
Authors: Crespo, M Pascual, M Tolkoff-Rubin, N Mauiyyedi, S Collins, AB Fitzpatrick, D Farrell, ML Williams, WW Delmonico, FL Cosimi, AB Colvin, RB Saidman, SL
Citation: M. Crespo et al., Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics, TRANSPLANT, 71(5), 2001, pp. 652-658
Transplantation of ABO-A2 kidneys to blood group B or O recipients - Too many unanswered questions
Authors: Saidman, SL
Citation: Sl. Saidman, Transplantation of ABO-A2 kidneys to blood group B or O recipients - Too many unanswered questions, TRANSPLANT, 69(7), 2000, pp. 1532-1533
Complement activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries
Authors: Collins, AB Schneeberger, EE Pascual, MA Saidman, SL Williams, WW Tolkoff-Rubin, N Cosimi, AB Colvin, RB
Citation: Ab. Collins et al., Complement activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries, J AM S NEPH, 10(10), 1999, pp. 2208-2214
Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies
Authors: Porter, DL Connors, JM Van Deerlin, VMD Duffy, KM McGarigle, C Saidman, SL Leonard, DGB Antin, JH
Citation: Dl. Porter et al., Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies, J CL ONCOL, 17(4), 1999, pp. 1234-1243
Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects afternon-myeloablative therapy and HLA-mismatched bone-marrow transplantation
Authors: Sykes, M Preffer, F McAfee, S Saidman, SL Weymouth, D Andrews, DM Colby, C Sackstein, R Sachs, DH Spitzer, TR
Citation: M. Sykes et al., Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects afternon-myeloablative therapy and HLA-mismatched bone-marrow transplantation, LANCET, 353(9166), 1999, pp. 1755-1759
Untitled - Response
Authors: Saidman, SL Pascual, M Tolkoff-Rubin, N Cosimi, AB Delmonico, FL
Citation: Sl. Saidman et al., Untitled - Response, TRANSPLANT, 68(4), 1999, pp. 592-593
A 49-year-old woman with thrombotic thrombocytopenic purpura and severe dyspnea during plasmapheresis and transfusion - Transfusion-related acute lung injury. Thrombotic thrombocytopenic purpura
Authors: Popovsky, MA Saidman, SL Shepard, JO Colvin, RB Mark, EJ
Citation: Ma. Popovsky et al., A 49-year-old woman with thrombotic thrombocytopenic purpura and severe dyspnea during plasmapheresis and transfusion - Transfusion-related acute lung injury. Thrombotic thrombocytopenic purpura, N ENG J MED, 339(27), 1998, pp. 2005-2012
Risultati: 1-9 |